Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction
Open Access
- 27 June 2015
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 32 (6) , 605-622
Abstract
Most kidney cancers are renal cell carcinomas (RCC). RCC lacks early warning signs and 70 % of patients with RCC develop metastases. Among them, 50 % of patients having skeletal metastases developed a dismal survival of less than 10 % at 5 years. Therefore, exploring the key driving proteins and pathways involved in RCC bone metastasis could benefit patients’ therapy and prolong their survival. We examined the difference between the OS-RC-2 cells and the OS-RC-2-BM5 cells (subpopulation from OS-RC-2) of RCC with proteomics. Then we employed Western-blot, immunohistochemistry and the clinical database (oncomine) to screen and verify the key proteins and then we analyzed the functions and the related pathways of selected key proteins with system biology approaches. Our proteomic data revealed 26 significant changed spots (fold change 1.9, P < 0.05) between two cells. The Western blotting results validated for these identified spots were consistent with the proteomics’. From the public clinical database, 23 out of 26 proteins were connected with RCC metastases and 9 out of 23 with survival time directly (P < 0.05). Finally, only 8 out of 9 proteins had significantly positive results in tissues of RCC patients with bone metastasis compared with primary tumor (P < 0.05). System biology analyzing results showed these eight proteins mainly distributed in oxidative phosphorylation which indicates that mitochondria dysfunction played the critical role to regulate cells metastasis. Our article used a variety of experimental techniques to find eight proteins which abnormally regulated mitochondrial function to achieve a successful induction for RCC metastasis to bone.Keywords
This publication has 50 references indexed in Scilit:
- Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancerBMC Cancer, 2013
- Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactorsProceedings of the National Academy of Sciences, 2012
- Ezrin regulates microvillus morphogenesis by promoting distinct activities of Eps8 proteinsMolecular Biology of the Cell, 2012
- Participation of the Cl−/HCO3− Exchangers SLC26A3 and SLC26A6, the Cl− Channel CFTR, and the Regulatory Factor SLC9A3R1 in Mouse Sperm Capacitation1Biology of Reproduction, 2012
- NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policyNucleic Acids Research, 2011
- Mitotic Modulation of Translation Elongation Factor 1 Leads to Hindered tRNA Delivery to RibosomesJournal of Biological Chemistry, 2011
- Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cellsOncogene, 2011
- Phenotypic characterization of skeletal abnormalities of Osteopotentia mutant mice by micro-CT: a descriptive approach with emphasis on reconstruction techniquesSkeletal Radiology, 2011
- Regulation of Expression of Microvillus Membrane Proteins by Estrogen in Baboon Fetal Ovarian Oocytes1Biology of Reproduction, 2008
- ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell MetastasisScience, 2008